Natural Adderall alternatives are getting a hard sell on Instagram, TikTok, and YouTube, where wellness influencers are promoting supplements and drinks as gentler routes to focus, calm, and emotional balance, WIRED reported. ADHD specialists told the publication the ads risk steering people away from stimulant medications that have a long evidence base and predictable side effects when used under medical supervision.
The marketing push is running alongside a federal fight over psychiatric drugs. In May 2025, Health and Human Services secretary Robert F. Kennedy Jr.’s Make America Healthy Again Commission released a report on childhood chronic disease that included a section on what it called “The Overmedicalization of Our Kids.” Kennedy has also claimed people have been “poisoned” by psychiatric medications, including stimulants used to treat ADHD, and HHS has moved toward further limits on access to those drugs, according to WIRED and The Hill.
Brands named by WIRED include Graymatter Labs, Stasis, Magic Mind, Thesis, and Nello. Their products contain ingredients such as L-theanine, ashwagandha, turmeric, B vitamins, and other compounds marketed as nootropics or adaptogens. The pitch is familiar: prescription stimulants are framed as harsh, jittery, or emotionally disruptive, while the supplement bottle gets cast as the clean little hack.
Are natural Adderall alternatives approved by the FDA?
Dietary supplements do not have to prove safety or effectiveness to the Food and Drug Administration before companies sell them. That is the regulatory gap experts flagged to WIRED: supplement makers can market focus and mood benefits without the premarket approval required for prescription drugs.
Some ads and testimonials directly compare the products with ADHD medications. WIRED cited a March paid partnership video in which creator Katie Silbar promoted Thesis, saying she had used Adderall from college into her late twenties and later decided she did not want to use a stimulant. Thesis sells jars with formulas such as “Motivation” and “Neuroprotection” for $59.
Magic Mind has shared clips describing Adderall as addictive, according to WIRED. Adderall and Vyvanse can be misused and are classified by the federal government as Schedule II controlled substances, but medical experts emphasize they are safe and effective when taken as prescribed and supervised. Graymatter Labs’ social accounts have featured a father saying its Bright Mind drink mix helped with mood swings he attributed to Adderall.
Stasis markets its supplements as a companion to stimulant treatment rather than a replacement, WIRED reported, but its ads still portray prescription drugs as incomplete. One Instagram post cited by WIRED referred to an afternoon Adderall crash and said scientists at Yale created Stasis. The company sells subscription bundles for up to $79 a month.
None of the companies named by WIRED responded to its questions about their scientific claims or the risk of nudging people away from ADHD medication. Meta declined to comment on the record. TikTok also declined to comment, though a US spokesperson told WIRED several brand accounts had been removed under its health misinformation rules. YouTube spokesperson Boot Bullwinkle said the same brand accounts did not violate YouTube’s guidelines.
Kristen Leinung, a mental health nurse practitioner and director of psychiatric services at the Northwest ADHD Treatment Center in Portland, Oregon, told WIRED that stimulant medications have been used for nearly a century and have been approved for children since the 1960s. She said the ad style adds to stigma around stimulants and could encourage people to stop medication, which she warned can harm quality of life.
Cindy Goldrich, a mental health counselor, educator, and ADHD coach in Boulder, Colorado, told WIRED the ads feel exploitative during ongoing shortages of Adderall, Vyvanse, Ritalin, and Concerta. The shortages began in 2022, and the nonprofit Understood has reported continuing supply problems despite higher Drug Enforcement Administration production quotas last fall.
Andrew Kahn, a psychologist and associate director of expertise and behavioral health at Understood, told WIRED the supplements imply medication-like benefits without solid evidence. HHS press secretary Emily G. Hilliard told WIRED the department is focused on informed consent, transparency, and evidence-based alternatives. Takeda Pharmaceuticals, which makes Vyvanse and extended-release Adderall, said treatment decisions should be made by a patient’s health care provider.
This story draws on original reporting from WIRED.
